Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 24, 2021
Prediction of esophagogastric varices associated with oxaliplatin administrationYosuke Satta, Ryuta Shigefuku, Tsunamasa Watanabe, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|March 26, 2016
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?Hiroki Ikeda, Chiaki Okuse, Tsunamasa Watanabe, et al.
International Journal of Molecular Sciences|September 21, 2016
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C VirusRyuta Shigefuku, Hideaki Takahashi, Hiroyasu Nakano, et al.
Journal of Medical Virology|June 23, 2016
Impact of resistance-associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevirHiroki Ikeda, Tsunamasa Watanabe, Chiaki Okuse, et al.
Journal of Gastroenterology|February 12, 2013
Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapyHideaki Takahashi, Michihiro Suzuki, Ryuta Shigefuku, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 27, 2019
Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosisRyuta Shigefuku, Motoh Iwasa, Kazuhiro Katayama, et al.
Clinical Journal of Gastroenterology|June 28, 2018
Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapyRyuta Shigefuku, Tsunamasa Watanabe, Takuro Mizukami, et al.
Hepatology International|December 8, 2022
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
BMJ Open|November 24, 2024
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocolMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, et al.
Pageof 6